BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

167 related articles for article (PubMed ID: 17982196)

  • 1. [Renal osteodystrophy and vitamin K. Vitamin K and dialysis].
    Okuno S; Ishimura E
    Clin Calcium; 2007 Nov; 17(11):1745-50. PubMed ID: 17982196
    [TBL] [Abstract][Full Text] [Related]  

  • 2. [Serum vitamin K concentration and nutrition].
    Tsugawa N; Okano T
    Clin Calcium; 2007 Nov; 17(11):1717-26. PubMed ID: 17982192
    [TBL] [Abstract][Full Text] [Related]  

  • 3. 1alpha(OH)D3 One-alpha-hydroxy-cholecalciferol--an active vitamin D analog. Clinical studies on prophylaxis and treatment of secondary hyperparathyroidism in uremic patients on chronic dialysis.
    Brandi L
    Dan Med Bull; 2008 Nov; 55(4):186-210. PubMed ID: 19232159
    [TBL] [Abstract][Full Text] [Related]  

  • 4. [Clinical significance of PTH (1-84) and PTH (7-84) in patients with predialysis chronic renal failure in relation to bone metabolism markers].
    Tsuchida T; Ishimura E; Hirowatari K; Matsumoto N; Jono S; Miki T; Inaba M; Nishizawa Y
    Clin Calcium; 2005 Sep; 15 Suppl 1():156-60; discussion 160. PubMed ID: 16272650
    [TBL] [Abstract][Full Text] [Related]  

  • 5. [Vitamin K and bone quality].
    Hara K; Akiyama Y
    Clin Calcium; 2007 Nov; 17(11):1678-84. PubMed ID: 17982187
    [TBL] [Abstract][Full Text] [Related]  

  • 6. The role of cyclase activating (CAP) and cyclase inhibiting (CIP) parathormone fractions in the assessment of bone metabolism disturbances in women with hyperprolactinemia of various origin.
    Zadrozna-Sliwka B; Bolanowski M; Jawiarczyk A; Kaluzny M; Syrycka J
    Neuro Endocrinol Lett; 2008 Feb; 29(1):178-84. PubMed ID: 18283239
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [K/DOQI clinical practice guidelines for bone metabolism and disease in CKD].
    Sakaguchi T; Akizawa T
    Clin Calcium; 2004 Sep; 14(9):9-14. PubMed ID: 15577103
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Vitamin K supplementation does not significantly impact bone mineral density and biochemical markers of bone in pre- and perimenopausal women.
    Volpe SL; Leung MM; Giordano H
    Nutr Res; 2008 Sep; 28(9):577-82. PubMed ID: 19083462
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Vitamin K and D Supplementation and Bone Health in Chronic Kidney Disease-Apart or Together?
    Ziemińska M; Sieklucka B; Pawlak K
    Nutrients; 2021 Mar; 13(3):. PubMed ID: 33804453
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [Biochemical markers of bone turnover. New aspect. Dialysis and bone metabolic marker].
    Okuno S; Inaba M
    Clin Calcium; 2009 Aug; 19(8):1084-91. PubMed ID: 19638691
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [Dynamics of bone biochemical markers in nephrotic children treated with prednisone and metabolites of vitamin D].
    Wojnar J; Roszkowska-Blaim M; Pańczyk-Tomaszewska M
    Przegl Lek; 2007; 64(9):552-8. PubMed ID: 18510075
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [Vitamin K2 as a potential therapeutic agent for glucocorticoid-induced osteoporosis].
    Tanaka I; Oshima H
    Clin Calcium; 2007 Nov; 17(11):1738-44. PubMed ID: 17982195
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Serum markers of bone turnover in children and adolescents with classic galactosemia.
    Gajewska J; Ambroszkiewicz J; Radomyska B; Chełchowska M; Ołtarzewski M; Laskowska-Klita T; Milanowski A
    Adv Med Sci; 2008; 53(2):214-20. PubMed ID: 18650146
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Healthy children with frequent fractures: how much evaluation is needed?
    Olney RC; Mazur JM; Pike LM; Froyen MK; Ramirez-Garnica G; Loveless EA; Mandel DM; Hahn GA; Neal KM; Cummings RJ
    Pediatrics; 2008 May; 121(5):890-7. PubMed ID: 18450891
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Vitamin D deficiency and associated factors in hemodialysis patients.
    Jean G; Charra B; Chazot C
    J Ren Nutr; 2008 Sep; 18(5):395-9. PubMed ID: 18721733
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [Treatment of primary osteoporosis with vitamin K2].
    Hosoi T
    Clin Calcium; 2007 Nov; 17(11):1727-30. PubMed ID: 17982193
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [Biological marker for bone turnover: Serum osteocalcin].
    Chaki O
    Nihon Rinsho; 2007 Nov; 65 Suppl 9():245-9. PubMed ID: 18161113
    [No Abstract]   [Full Text] [Related]  

  • 18. Evaluation of bone mineral density and bone metabolism in children with multiple bone fractures.
    Michałus I; Chlebna-Sokół D; Rusińska A; Jakubowska-Pietkiewicz E; Kulińska-Szukalska K
    Ortop Traumatol Rehabil; 2008; 10(6):602-12. PubMed ID: 19153549
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Diagnosis of osteoporosis with vitamin k as a new biochemical marker.
    Heiss C; Hoesel LM; Wehr U; Wenisch S; Drosse I; Alt V; Meyer C; Horas U; Schieker M; Schnettler R
    Vitam Horm; 2008; 78():417-34. PubMed ID: 18374203
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Determinants of bone mass in end-stage renal failure patients at the time of kidney transplantation.
    Dolgos S; Hartmann A; Bønsnes S; Ueland T; Isaksen GA; Godang K; Pfeffer P; Bollerslev J
    Clin Transplant; 2008; 22(4):462-8. PubMed ID: 18318737
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.